Ramsay Zachary J A, Bartlett Rachel E, Clarke Christine A, Asnani Monika R, Knight-Madden Jennifer M, Gordon-Strachan Georgiana M
Caribbean Institute for Health Research-Sickle Cell Unit, The University of the West Indies Mona Campus, Kingston, Jamaica.
The Department of Economics, The University of the West Indies Mona Campus, Kingston, Jamaica.
Health Equity. 2021 Apr 21;5(1):210-217. doi: 10.1089/heq.2021.0002. eCollection 2021.
In an effort to transition toward universal health coverage (UHC), Jamaica abolished user fees at all public health facilities in 2008. We aimed to determine the extent of out-of-pocket payments (OPPs) and the other cost barriers to UHC among patients with sickle cell disease (SCD). Patients presenting to the Sickle Cell Unit in Kingston, Jamaica, for routine care between October 2019 and August 2020 were consecutively recruited and interviewed about their latest hospitalization within the previous 4 weeks. Parents or guardians completed the questionnaire on behalf of pediatric patients. The questionnaire included the Patient Satisfaction Questionnaire Short Form (PSQ)-18 and the health module of the Jamaica Survey of Living Conditions. There were 103 patients with ages ranging from 7 months to 56 years (51.5% female, 60.2% public hospitalizations, and 54.4% pediatric). The modal income (J$6200-$11,999 per week) was similar to the minimum wage and 48.5% lived in overcrowded households. Government drug-subsidy cards were owned by 39.8%. OPPs were made by 19.4% of persons for items and tests that were unavailable at public facilities. There were no costs reported by 69.6%, who visited public pharmacies. Similarly, the cost of admission to public hospitals was free for 95.4% of subjects. Using public transportation, private hospitalization, and having more disease complications were predictive of a perception that health care is unaffordable. Most SCD subjects reported no expense with public hospitalizations; however, approximately one in five reported OPPs. Efforts are needed to increase the availability of subsidized items, and the use of drug-subsidy cards, to improve UHC.
为了向全民健康覆盖(UHC)过渡,牙买加于2008年取消了所有公共卫生设施的用户收费。我们旨在确定镰状细胞病(SCD)患者的自付费用(OPPs)程度以及全民健康覆盖的其他成本障碍。2019年10月至2020年8月期间,在牙买加金斯敦镰状细胞病治疗中心接受常规治疗的患者被连续招募,并就其在过去4周内的最新住院情况接受访谈。父母或监护人代表儿科患者填写问卷。问卷包括患者满意度问卷简表(PSQ)-18和牙买加生活条件调查的健康模块。共有103名患者,年龄从7个月到56岁不等(女性占51.5%,60.2%在公立医院住院,54.4%为儿科患者)。中等收入(每周6200 - 11999牙买加元)与最低工资相似,48.5%的人生活在拥挤的家庭中。39.8%的人拥有政府药品补贴卡。19.4%的人因公共设施没有的项目和检查支付了自付费用。69.6%去公共药房的人没有报告任何费用。同样,95.4%的受试者公立住院费用免费。使用公共交通、私立住院以及有更多疾病并发症预示着认为医疗保健负担不起。大多数镰状细胞病受试者报告公立住院没有费用;然而,约五分之一的人报告了自付费用。需要努力增加补贴项目的可及性以及药品补贴卡的使用,以改善全民健康覆盖。